Evotec SE (EVO, EVOTF) proposed Dieter Weinand as Chairman of its Supervisory Board at the Annual General Meeting scheduled for June 11. This is a routine corporate governance nomination from the German drug discovery and development company and is unlikely to have a material impact on operations or the share price.
Evotec SE (EVO, EVOTF) proposed Dieter Weinand as Chairman of its Supervisory Board at the Annual General Meeting scheduled for June 11. This is a routine corporate governance nomination from the German drug discovery and development company and is unlikely to have a material impact on operations or the share price.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
